Skip to main content
. Author manuscript; available in PMC: 2011 Sep 27.
Published in final edited form as: Circulation. 2011 Sep 13;124(11 Suppl):S62–S69. doi: 10.1161/CIRCULATIONAHA.110.002543

Figure 2.

Figure 2

The propensity adjusted relative risk for early post-operative adverse events in the aprotinin group versus the lysine analogue group. Overall, the propensity adjusted analysis failed to identify any risk reduction in significant peri-operative adverse events in the post-aprotinin era. Indeed, there was a trend for a reduction in the risk of respiratory in the aprotinin group (p=0.06). Although the propensity adjusted risk of renal failure was reduced in the aprotinin group, this was not significant (p=0.13).